RxDoctor Payments Data

Luay Haddad, MD

Psychiatry · Detroit, MINPI 1538106059

Payments from drug & device makers

$3,455in general payments, 2019–2025

Across 195 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$1K
  • Johnson & Johnson$661
  • Otsuka America Pharmaceutical, Inc.$444
  • Indivior Inc.$435
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$404
  • Lundbeck LLC$94
  • plus $402 from 9 others

What the payments were for

  • Food & beverage$3,36197%
  • Education$943%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,455 in reported general payments places this provider in the 85th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$181,283
Medicare patients
216
Services billed
2,441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate207$772,819
Abilify MaintenaAripiprazole131$366,764
Haloperidol Decanoate495$28,661
Aripiprazole OdtAripiprazole13$19,037
Fluphenazine Decanoate220$17,213
Lurasidone Hcl40$7,530
Fluphenazine Hcl58$4,913
Clozapine78$4,566
Haloperidol126$4,014
Olanzapine337$3,849
Divalproex Sodium164$3,831
Aripiprazole206$3,625
Quetiapine Fumarate310$3,358
Trimipramine Maleate12$2,919
Clonazepam443$2,442

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$661$772,819207 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$444$366,764131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →